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Abstract (246 words, excluding headings) 
Introduction and aim: The British Columbia Adult Haemophilia Team recently adopted a 
patient-centred care approach. The team presented visual information on an individual’s 
pharmacokinetic profile and bleed history and encouraged patients to participate in treatment 
decisions. This qualitative study explored how this approach changed patients’ understanding 
of haemophilia and how it facilitated them to make treatment decisions. 
Methods: We interviewed 18 males with mild, moderate or severe haemophilia, using a 
convenience sample from the adult haemophilia clinic at St. Paul’s hospital in Vancouver, 
Canada. Interviews were recorded and transcribed verbatim and analysed using descriptive 
content analysis. 
Results: Most participants reported that reviewing visual information with the clinic team 
helped them in their communication with their care providers during their annual review clinic 
appointment. Despite this improved communication, for some the most important feature of 
their treatment was that they had switched from on-demand treatment to prophylactic 
treatment in recent years and were able to prevent bleeds. Almost half of the participants 
reported that the visual information presented increased their understanding of haemophilia 
and the pharmacokinetics of coagulation factor. Three patients improved their treatment 
adherence or had changed their prophylaxis schedules based on this. Most participants felt 
they were involved in decision-making about their treatment schedule, which they 
appreciated. On the other hand, two participants thought the clinic team should make these 
decisions. 
Conclusion: Participants perceived the patient-centred prophylaxis approach helpful because it 
enhanced communication with the clinic team, increased their understanding of haemophilia 
and pharmacokinetics of coagulation factor and facilitated treatment decisions.  
 








Over the last decades, the availability of treatment has improved life expectancy of people 
with haemophilia (PWH)[2] and decreased bleeding rates and joint impairment.[3]  
While guidelines exist for preventing and managing bleeds, the optimal dosing strategy is 
variable,[1] due to differences in pharmacokinetics[5] and bleeding phenotypes between 
patients.[6] This variability provides an opportunity for patients to be involved in the decision-
making process in their disease management,[7] for example in determining the timing and 
frequency of coagulation factor administration.  
Patient-centred care is increasingly being promoted in order to deliver high-quality care,[8] 
including in haemophilia.[9] Dimensions of patient-centred care include respect for patients’ 
preferences; coordination and integration of care; information and education; physical 
comfort; emotional support; involvement of family or friends; continuity and transition; and 
access to care.[8,10] Research suggests that patient-centred care may positively affect 
patients’ disease management skills, which has been shown to improve adherence and health 
outcomes in a range of conditions.[11-12]  
In British Columbia, Canada, some PWH had not attended a regular haemophilia review clinic 
recently. Also, some with severe haemophilia started long-term prophylaxis within the past 5-
10 years.[13] Therefore, the Clinic Team piloted a new patient-centred “prophylaxis clinic” 
approach in order to improve patient engagement, individualize prophylaxis regimes, and 
improve health outcomes. The approach consisted of 1) a shift in focus from adherence to 
prophylaxis toward a more comprehensive approach that included PWH’s preferences and 
needs to manage their lives with haemophilia, 2) sharing and discussing visuals of a patient’s 
bleeds and treatment history, and individualized pharmacokinetic (PK) profiles where 
appropriate. The approach was aimed at facilitating shared decisions about treatment.   
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A better understanding of how PWH perceive these patient-centred strategies is needed. With 
this knowledge, haemophilia care can be improved further, eventually resulting in better 
outcomes for PWH. Therefore, we conducted a qualitative study that aimed to describe PWH’s 




We conducted a qualitative study in 2016 and 2017 to gain insight into perspectives of PWH on 
the patient-centred prophylaxis clinic. We invited people who were scheduled for their regular 
clinic review appointment to participate in an interview study (convenience sampling) with the 
intent to obtain a diverse sample of people regarding their age, self-reported type and severity 
of disease, country of birth and education level.  Topic lists used during the interviews included 
questions on participants’ perspectives on how their needs were addressed, data visualization 
and participation in decision-making. In 2017, the interview questions were revised to reflect 
the change in practice of the prophylaxis clinic approach. The topic list is included in the 
Supplement. Interviews were recorded and transcribed verbatim. 
Setting 
The new patient-centred prophylaxis clinic had been piloted as part of a larger approach to 
engage patients, individualize prophylaxis schedules and stimulate shared decision-making for 
those with severe haemophilia. The prophylaxis clinic was an addition to regular haemophilia 
clinic appointments and consisted of a meeting between the PWH and all members of the 
treatment team (haematologist, nursing specialist, physiotherapist).  Two types of graphs were 
shown on a large screen: 1) an individual PK profile and 2) treatment and bleeds frequency 
data.  Individual PK data were obtained from the Web Accessible Population Pharmacokinetic 
Service; WAPPS. WAPPS can be used to simulate the effects of different dosing regimens on 
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peak and trough levels. Treatment and bleeds frequency data were obtained from the on-line 
Inherited Coagulopathy and Hemoglobinopathy Information Portal; iCHIP. Examples of graphs 
shown during prophylaxis clinic are shown in Figures 1 and 2. More information about iCHIP 
and WAPPS is included in the Supplement. 
[figure 1] 
[figure 2] 
The prophylaxis clinic format was piloted in 2015 and 2016. By 2017, the prophylaxis clinic 
approach as described above (i.e. focus on patients’ needs and stimulating participants in 
decisions) was integrated in all clinic visits. The approach was also used for those with mild 
haemophilia and those treated on-demand. 
Interviews and participants 
The study was conducted in two phases (13 interviews in March and April 2016 and 5 in May 
2017). Participants were eligible for the study if they had participated in the prophylaxis clinic 
(people with severe haemophilia) or if they had attended their annual review clinic in 2016 or 
2017. People with mild haemophilia had not been shown individualized PK and bleed graphs 
during their scheduled review appointment but had an opportunity to look at anonymized PK 
data during the interviews. They were also asked about how the clinic addressed their needs 
and about their participation in decision-making.  
The first author, a PhD student in clinical epidemiology and some knowledge of qualitative 
research methodology, and the second author, a medical anthropologist with experience in 
ethnographic research, conducted semi-structured interviews.  
The study team approached potential participants two weeks before their scheduled 
outpatient clinic appointment by a letter that explained the study procedures. All invited 
participants provided informed consent. 
Analyses 
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The software program MAXQDA (version 12) was used for coding and organization. Qualitative 
data from the interviews were analysed using descriptive content analysis as described by 
Green and Thorogood.[14] The first author read and summarized all the transcripts. Several 
rounds of coding were applied to understand the data in their context. Then, the same 
researcher identified themes in the data set based on the research question. Codes and larger 
themes were discussed and refined through a series of analysis meetings with the research 
team. 
Ethical considerations 
Approval for this study was obtained from St. Paul’s Hospital’s Research Ethics Board as part of 
a larger study about integrating a Quality of Life Assessment and Practice Support System in 
Routine Clinical Practice (QPSS).[15]  
 
Results 
Participants in our study reflected the variety of people with haemophilia receiving treatment 
from the British Columbia Adult Haemophilia Interdisciplinary Team. Their ages ranged from 
20 to 76 years old; twelve had haemophilia A and 6 had haemophilia B. Eight had severe, four 
had moderate and six had mild haemophilia (self-report). Of the participants with severe 
haemophilia, seven were on a regular prophylaxis regimen, but only one of them had been on 
prophylaxis since he was a child. PK data were available for six participants (one with mild 
haemophilia, two with moderate haemophilia and three with severe haemophilia). Three 
others were scheduled for PK in the near future. iCHIP data were available for eleven 
participants. Participants’ characteristics are summarized in table 1. 
[table 1] 
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Participants’ perspectives were grouped into three main topics: 1) communication with the 
Clinic Team, 2) understanding the effects of treatment and 3) active participation in treatment 
decisions.  
Communication with Clinic Team 
All eleven iCHIP users (two with mild, four with moderate, five with severe haemophilia) 
reported that reviewing their treatment and bleeds history data in a visual format was useful 
to them. Four of them (three severe, one mild with a severe bleeding phenotype) said that it 
made their annual review appointment more focused, because the bleeds and infusion history 
data from iCHIP helped them remember the bleeds they had in the past year and the amount 
of coagulation factor they used. A few patients commented that they were well aware of their 
own bleed and infusion history because they had tracked it in the app themselves. However, 
they still found it useful to review this information together with the Team. As participant 6  
puts it (see box 1):  
[box 1] 
Because the interactive WAPPS program visualized the effects of infusions on trough levels for 
people with severe haemophilia, it also facilitated the conversation about further 
individualizing the patient’s prophylaxis schedule.  
 
Four participants (three severe, one mild) reported that they felt connected to the team 
because of iCHIP, because it automatically sends a message to the clinic when a bleed is 
registered (which may or may not be real-time). Although the alerts are not systematically 
monitored, participant 1 felt safe knowing that the clinic staff has access to his bleeds data in 
case he wants to discuss his bleeds (see box 2). 
[box 2] 
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Nine participants (one mild, two moderate and six severe) said they felt comfortable discussing 
any issues with their treatment team and felt attended to in their treatment needs. Participant 
7 commented that the patient-centred prophylaxis clinic approach was also useful because it 
improved communication about needs that were not directly treatment-related. As he 
explained (box 3): 
[box 3] 
Though useful for most participants, three of them (two severe and one mild) pointed out that 
the visual information presented was of less importance compared to actual bleed prevention 
and treatment. Two of them had struggled with bleeds in the past and had only recently 
switched to prophylaxis. In the words of participant 11 [box 4]: 
[box 4] 
Finally, two participants (both with severe haemophilia) said it was more important for the 
team to track their bleeds and treatment data than it was for themselves. However, they 
thought they would benefit from the information in the long-term because they thought it 
helped the clinic team gain insight into their bleeds history.  
In summary, participants felt visualizing their treatment-related data helped them better 
communicate with the Clinic Team. 
Understanding the effects of treatment  
Seven participants (two mild, one moderate, four severe) said visual information about their 
bleed history or PK data increased their understanding of both their condition and the effects 
of coagulation factor infusions. They reported a better understanding of their trough levels 
and how their factor levels were affected by infusion with coagulation factor. For participant 3 
the visual information made him feel more comfortable because he now understood that if he 
had a bleed, it was because his factor IX level was low. It also made him realize that he should 
take prophylaxis seriously (box 5):  




Participant 7 changed his approach based on this new knowledge of his personal PK data (box 
6). 
[box 6] 
Participant 15 commented that tracking his bleeds and infusions helped him adhere to his 
prophylaxis regimen better, because he seemed to realize that bleeds occurred when he did 
not take his prophylaxis (box 7).  
[box 7] 
Two participants with mild haemophilia who had not had personal PK profiling themselves, 
had been shown sample population PK profiles during review clinic. They said they would be 
interested in knowing their personal coagulation factor levels before and after treatment. One 
participant felt the benefit might be that he would be able to continue his active lifestyle 
without bleeding. 
In summary, patients felt visualizations helped them understand their condition and the 
effects of treatment with coagulation factor. 
Participating in treatment decisions 
A majority of ten participants (four mild, six severe) said they were actively encouraged by the 
Clinic Team to participate in decisions about dosing and frequency of on-demand or 
prophylactic treatment. They perceived they had the freedom to adjust their schedules to their 
needs and base it on their experience. Participant 12 explained that he has the freedom to 
infuse extra before physical activities (box 8). 
[box 8] 
Participant 7 commented that for larger changes in his schedule, he would contact the Clinic 
Team. He makes smaller changes on his own (box 9). 
[box 9] 
Van Balen et al. 2019 - patient perspectives on patient-centred care 
12 
 
All eight participants with severe haemophilia, one with moderate and two with mild 
haemophilia appreciated that they were encouraged to make decisions about dosing and 
frequency of prophylactic or on-demand treatment. Two participants, one with moderate and 
one with mild haemophilia, said the doctor should make the decisions about treatment, 
because they were the experts. Both of these participants had experienced few bleeding 
problems. 
Twelve participants had switched to a prophylactic treatment schedule from on-demand 
treatment only in the past five to ten years. They felt the decision to start prophylaxis was a 
joint decision with the Clinic Team. For some of them, determining dosing and frequency of 
prophylaxis involved some negotiation with the Clinic Team. Participant 3 felt more 




The goal of this exploratory study was to gain insight into participants’ perspectives on the 
new patient-centred prophylaxis clinic approach used by the British Columbia Adult 
Haemophilia Interdisciplinary Team. This approach included the use of visual representations 
of condition-related information and stimulating patients to participate in their treatment 
decisions. We found that this approach enhanced communication with the Clinic Team. It also 
increased understanding of haemophilia and treatment effects, particularly through visualizing 
individualized PK profiles and bleed and infusion history data. Participants also found the 
prophylaxis clinic approach useful because they perceived the freedom to participate in 
treatment decisions.  
Patient-centred care is a widely-recommended practice in haemophilia.[9] Our results, based 
on the perspectives of patients, suggest that  visualization techniques could be a helpful 
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patient-centred care strategy. First, tools such as iCHIP and WAPPS may help increase patients’ 
understanding, even for those with mild haemophilia. A previous qualitative study 
demonstrated that a better understanding determines the ability to practice prophylaxis. This, 
in turn, determines self-reported adherence.[16] Reviews have also shown that a better 
understanding improves self-management skills and adherence in haemophilia.[17-18] In 
another study,[19] the use of an app similar to iCHIP was associated with an improvement in 
patient adherence to prophylactic treatment in one year. This resulted in increased patient 
quality of life (QoL) and enhanced illness perception and stabilization of joint health after one 
year.[19] In concordance with previous studies, PWH in our sample also reported that iCHIP 
served as a good reminder for their infusions, possibly improving adherence. It should be 
noted that aids such as iCHIP only work if PWH are engaged in their care and feel comfortable 
to accurately record their data. 
A second benefit of the prophylaxis clinic approach is that it may improve patient-clinician 
communication, strengthening the relationship. This patient engagement was an important 
objective of the British Columbia Adult Haemophilia Interdisciplinary Team. Both people with 
severe and with non-severe haemophilia in our sample found it useful to use visuals in their 
interaction with the Team. Indeed, a good relationship between care providers and PWH has 
been found to be associated with treatment adherence in haemophilia.[17-18]  
A third potential advantage of the prophylaxis clinic approach is improved patient participation 
in decisions about their treatment schedules. The Team has encouraged people with severe 
haemophilia to switch to prophylaxis from on-demand treatment. Participation in decision-
making may improve adherence and reduce bleeds,[13] as some participants in our sample 
reported. Whether this leads to an actual improvement in outcomes needs to be investigated 
further. As life-long experts, PWH may feel they have the knowledge to make their own 
treatment decisions. Indeed, in our study, many PWH perceived they had the freedom to make 
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their own decisions. Making decisions about dosing and frequency of prophylaxis or on-
demand treatment is important in haemophilia due to the lack of a standard treatment 
regimen and inter-individual differences in response to treatment.[1,5-6] Decision aids such as 
pamphlets, videos or web-based tools can be used to support treatment decisions. 
Information about different options and their harms and benefits may be presented in 
graphical formats.[20-21] Several decision aids have been developed for haemophilia.[22] Yet, 
to the best of our knowledge, we are not aware of any tools available for decisions such as 
setting a treatment schedule. Naturally, these tools are particularly relevant for those on 
prophylaxis. Also, people with mild haemophilia may benefit from a better understanding of 
how their factor levels change after an infusion. This may make them feel more comfortable in 
managing a bleed, including altering their physical activity during recovery. 
A limitation of our qualitative study is that we cannot quantify the effect of the patient-
centred prophylaxis approach on health outcomes. Another limitation is that clinical factors 
such as joint status, duration of prophylaxis use and background bleeding phenotype likely 
affect how patients perceive patient-centred engagement efforts. Though we aimed to include 
a variety of patients, we may not have captured all possible patient perspectives. Still, this 
qualitative study helps understand how investing in the approach may positively affect self-
reports of patient outcomes such as satisfaction with care, a good relationship with the team, 
a better understanding and improved self-management skills. Further research is needed that 
quantitatively measures haemophilia outcomes longitudinally.  
Another potential limitation of this study is that the convenience sampling approach makes it 
more likely to include PWH who are already willing to accept their condition and its treatment 
and engage with the Clinic Team. However, we included a variety of PWH, including a few that 
had not been to clinic in recent years, thus representing perspectives of those who had not yet 
established a long-term relationship with the Clinic Team.  




Participants reported that the use of tools to visualize bleeds history and pharmacokinetic data 
enhanced patient-clinician communication. Also, it enabled PWH to better understand 
haemophilia and its treatment. Participants felt they were involved in decision-making about 
their treatment. Some of them found that the tools helped them to make better informed 
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Tables and figures  
Figure 1: Example of bleeds history data from iCHIP. The presented data are based on real 
patient data. These patients did not participate in the interviews and provided informed 
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Figure 2: Example of a personal pharmacokinetic profile based on a dose of 2000 IU and a 
dosing interval of 72 hours. Graphs are generated based on blood samples taken at two to 
three time points after infusion with factor VIII or IX. The WAPPS program can then be used by 
clinicians to simulate the effects on peak and trough levels if different dosing regimens are 
chosen.  The presented data are based on real patient data. These patients did not participate 
in the interviews and provided informed consent to use their data in this paper for illustration 








Table 1: Participant characteristics at the time of their interview
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Table 1: Participant characteristics at the time of their interview 
Characteristic  N = 18 
Mean age (range), years 37.7 (20-76) 
Type of haemophilia, n  
Haemophilia A 12 
Haemophilia B 6 
Severity, n  
Mild 6 
Moderate 4 
Severe  8 
Treatment type, n   
On-demand 6 
Prophylaxis  12 
On home therapy 15 
Education levela, n  
Upper secondary education 2 






Visualizations   
PK available 6 
Use iCHIP 11 
aEducation levels (finished or in progress) according to the International Standard Classification 
of Education (ISCED)[23] 
 
















“So I think they [the Clinic Team] should make it available to each person to look at their own 
data [of their bleeds history]. I mean, I can look, of course. I can go back to the history and I can 
print if I want. But the way [as a graph] they had it there was good because it showed a little bit 
what had happened, in my case, during the last year.” 
 
“Yeah, it's useful just to keep the record of the history. You can call them [the treatment team] 
back if any injury happens, like on the same joint back-to-back. So it's nice to have.” 
“I think there are absolutely two sides of medicine. You know, there’s a treatment side you have 
to understand (…) but then there’s also the more personal side of medicine where you need to 
check in on the patients, get a sense of the patient’s quality of life, how things are going for 
them. I thought it was useful that I was asked about how do I actually feel about having to treat 
myself every day”  
“And these [visualizations] have been really helpful with the little adjustments, but to be honest, 
from my perspective, the big change was just doing any kind of prophylaxis. (…) Like if I was 
someone who really loved molecular biology or statistics or graph making, these things might be 
more important. I just don't want to bleed.” 
“So the more information you get, the more comfortable I think that you are. (…) So I want to 
know everything. (…)  I just think [this is cool] information because then you can literally gauge it 
[factor level] to exactly the way that you feel and with the numbers. (…) Like, this says that you 
should have this much or whatever if you aren't as responsible with that [taking prophylaxis].” 














“It was good to see exactly how far my factors fall at the trough and then how far they spike up 
at their peak. And based off that, I've actually changed the way I do my infusions, day to day, a 
little bit.” 
“When I stick in my prophylaxis treatment it’s through the iCHIP program. When I was taking my 
prophylaxis treatment we don’t see any bleeds. But then when I kind of don’t enter anything 
[prophylaxis] for three or four days, we’ll see that I enter a bleed in there.” 
“Yes, we have freedom. We can basically make that decision, which is pretty good because… 
They like to have us independent, which is very good, and we have at-home treatment.” 
“A smaller change, I might probably make the decision on my own and then comment to them 
[the Clinic Team] that, "I'm doing this now. Is that okay?" But I'd say it's quite self-directed in a 
way, [but] with outside influence.” 
“I negotiate with them [treatment team], and I would feel more comfortable if I did just a little 
bit more [prophylaxis] to push myself a little bit so that I’m covered completely, 100%. But they 
like me to just be at the level where they know that I’m okay.”   




Topic list with interview questions (2017) 
Introductory / ice-breaking questions 
Can you tell me what it is like to live with haemophilia? 
What does your haemophilia care look like? (go through clinic appointment, what happens, 
what is discussed) 
Quality of life 
What topics related to living with haemophilia should be addressed during your clinic 
appointment? 
Information sharing 
What type of information do you receive from the clinic team, and in what format? 
What type of information has been or would be the most helpful or educational for you and 
why? (does it address needs and concerns, why or why not, how to deliver this information) 
Decision-making 
Can you describe how you make decisions about your care? 
 
Topic list with interview questions (2016) 
1. The haemophilia team has started a prophylaxis clinic that uses visual aids to chart 
your bleed history, factor utilization, and quality of life. 
a. Do you like the information being presented in this way?  
b. If yes, what do you like about the information being presented this way? 
c. If not, what don’t you like about the information being presented this way? 
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2. What is the most important information about your haemophilia that you want to 
know about? 
 
3. What is the most important information about your haemophilia that you want the 
team to know about?  
 
4. What is the most important information about your haemophilia treatment and 
support that would help you to determine if it is the best it can be?  
a. Is there additional or alternate information that is not currently collected that 
the clinic should be collecting and reporting back to you about? 
  
5. How do you think this information can be used by yourself and the clinical team to 
make shared decisions about your treatment?  
a. How would you like to see this information used in your care planning?  
 
6. Were you a participant in the recent project using the handheld tablets?  
a. If so, do you feel that they could be used in regular clinics to make your visit 
more efficient or educational for you?   
b. Can you describe any other ways of visualizing your data that would be helpful 
to you?  
 
7. Would you like the ability to create your own reports using data from other sources 
(e.g. iCHIP)?  
a. If yes, would you want to be able to send them to the clinic team and have 
them be part of the clinic appointment?  
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b. If no, why not? 
8. What do you think of having the prophylaxis clinic through a video link where you 
could see both visualized data and clinic staff from your home computer?  
 
9. What do you feel have been the most important changes in your haemophilia care in 
recent years?   
 
10. How has your quality of your day to day life changed since you’ve started prophylaxis? 
 
11. Do you feel that attending the prophylaxis clinic, in addition to the regular review 
clinic, has improved your haemophilia care?  
a. Why or why not?  
b. Do you feel any different in your relationship with the team as a result of 
attending the prophylaxis clinic in addition to the regular review clinic?  
 
12. Is there anything else you can think of that the team can do to improve your quality of 
life? 
 
Examples of graphs shown in clinic 
Most people with moderate or severe haemophilia in British Columbia use iCHIP for recording 
bleeds and factor use available as a smartphone app. The Team can review summary data 
during clinic appointments with PWH. The system can send an alert to the Clinic Team when a 
bleed is entered, however the arrival of the alert is dependent upon when the patient chooses 
to enter the data, and therefore often not “real-time”.  
Van Balen et al. 2019 - patient perspectives on patient-centred care 
6 
 
Personalized PK profiles had been created by WAPPS for five people in our sample (four people 
with severe haemophilia and one with mild haemophilia but a severe bleeding phenotype). 
The program was used to show peak and trough coagulation factor levels if frequency or 
dosing are changed.  
The presented data in the iCHIP and WAPPS examples are based on real patient data. These 
patients did not participate in the interviews and provided informed consent to use their data 
in this paper for illustration purposes. 
 
 
 
 
